General Surgical Innovations aims to expand minimally invasive surgery (MIS)
This article was originally published in Clinica
Executive Summary
General Surgical Innovations (GSI) aims to raise $27 million from the sale of 2.5 million shares at an assumed price of $12. The amount could rise to $31 million if the underwriters' overallotment is exercised in full. The developer of balloon dissection systems for minimally invasive surgery plans to use $9 million of the proceeds of its IPO to expand sales of its Spacemaker systems. Part of the IPO proceeds will go towards expanding GSI's facility in Palo Alto, California.